Pharmacists in Hugoton, KS Accepting Medicare
2 Pharmacists found. Showing 1 - 2
 Leigh Angell, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 531 S Main St, Hugoton, KS 67951 Phone: 620-544-4065 Fax: 620-544-7116 |
Madelaine Carol Rome, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1042 S Jackson St, Hugoton, KS 67951 Phone: 620-544-8512 |
News Archive
Exome sequencing leads to correct diagnosis and life-saving treatment for mysterious genetic disorder
A genetic testing approach called exome sequencing—which provides a clinically practical alternative to whole-genome sequencing—led to correct diagnosis and life-saving treatment in a child with a previously unknown genetic disease, reports an upcoming paper in Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
State roundup: Restraining order issued in Mo. health exchange fight
A judge issued a temporary restraining order Tuesday against Missouri's secretary of state, Robin Carnahan, to prevent her from finalizing the language of a ballot question on health insurance exchanges. Lt. Gov. Peter Kinder, a Republican, sought the restraining order while a state court considers whether the language of the ballot question is biased, a claim leveled by Kinder and the state's top Republicans.
New self-expanding peripheral stent system launched by Invatec
Invatec, a comprehensive innovator of interventional products, today launched their latest self-expanding peripheral stent system, Maris Plus. The Maris Plus stent has a "lesion-specific" design with larger sizes to meet the clinical requirements of the iliac region. The Maris Plus becomes the sixth stent platform now marketed by Invatec for the treatment of Peripheral Arterial Disease (PAD), greatly optimizing visibility, flexibility and ease of use for the physician.
40-year tale of investigation and innovation into the challenge of hip implant failure
A remarkable story of how a new disease was inadvertently caused by successful medical treatment, ultimately understood, and eventually defeated by scientific innovation is being told a major player in the process.
Standardized research approaches needed for developing new treatments for neurofibromatosis
As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).
› Verified 5 days ago